Supplement Industry’s ‘Golden Age’ Hits a Regulatory Wall

Supplement industry regulatory oversight intensified in early 2026, with MAHA priorities driving FDA modernization, state legislation, and mounting litigation pressure.

Supplement industry regulatory oversight intensified in early 2026, with MAHA priorities driving FDA modernization, state legislation, and mounting litigation pressure.

Over 180 NPA members hit Capitol Hill in 2026, pushing for dietary supplement regulatory access via HSAs, FSAs, and drug preclusion reform.